Visitor Monitoring Drug History: RELPAX
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: RELPAX
FDA Application No: (NDA) 021016
Active Ingredient(s): ELETRIPTAN HYDROBROMIDE
Company: PFIZER IRELAND
 
Label History
 
View the label approved on April 7, 2003 for RELPAX, (NDA) 021016


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
5/6/2004 003Labeling Revision Letter 
12/26/2002 000Approval Letter
Label
Review
Other Important Information from FDA 
 
©2019 Drugs That Causes a False Positive on a Drug Test